Literature DB >> 32138555

Reliability and validity of speech & pause measures during passage reading in ALS.

Carolina Barnett1,2, Jordan R Green3,4, Reeman Marzouqah5, Kaila L Stipancic3, James D Berry6, Lawrence Korngut7, Angela Genge8, Christen Shoesmith9, Hannah Briemberg10, Agessandro Abrahao11,12, Sanjay Kalra13,14, Lorne Zinman11,12,15, Yana Yunusova5,12,16.   

Abstract

Objective: The use of speech measures is becoming a common practice in the assessment of bulbar disease progression in amyotrophic lateral sclerosis (ALS). This study aimed to establish psychometric properties (e.g. reliability, validity, sensitivity, specificity) of speech and pause timing measures during a standardized passage.
Methods: A large number of passage recordings (ALS N = 775; Neurotypical controls N = 323) was analyzed using a semi-automatic method (Speech and Pause Analysis, SPA).
Results: The results revealed acceptable reliability of the speech and pause measures across repeated recording by the control participants. Strong construct validity was established via significant group differences between patients and controls and correlation statistics with clinical measures of overall ALS and bulbar disease severity. Speaking rate, pause events, and mean pause duration were able to detect ALS participants at the presymptomatic stage of bulbar disease with a good discrimination ability (AUC 0.81). Conclusions: Based on the current psychometric evaluation, performing passage recording and speech and pause timing analysis was deemed useful for detecting early and progressive changes associated with bulbar ALS.

Entities:  

Keywords:  Bulbar ALS; passage reading; pauses; reliability; speaking rate; validity

Mesh:

Year:  2019        PMID: 32138555      PMCID: PMC7080316          DOI: 10.1080/21678421.2019.1697888

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  20 in total

1.  A taxonomy for responsiveness.

Authors:  D E Beaton; C Bombardier; J N Katz; J G Wright
Journal:  J Clin Epidemiol       Date:  2001-12       Impact factor: 6.437

2.  Subjective experience and coping in ALS.

Authors:  Martin Hecht; Thomas Hillemacher; Elmar Gräsel; Sebastian Tigges; Martin Winterholler; Dieter Heuss; Max-Josef Hilz; Bernhard Neundörfer
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2002-12

3.  Cognitive-linguistic demands and speech breathing.

Authors:  H L Mitchell; J D Hoit; P J Watson
Journal:  J Speech Hear Res       Date:  1996-02

4.  The evaluation of bulbar dysfunction in amyotrophic lateral sclerosis: survey of clinical practice patterns in the United States.

Authors:  Emily K Plowman; Lauren C Tabor; James Wymer; Gary Pattee
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-04-20       Impact factor: 4.092

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  The diagnostic utility of patient-report and speech-language pathologists' ratings for detecting the early onset of bulbar symptoms due to ALS.

Authors:  Kristen M Allison; Yana Yunusova; Thomas F Campbell; Jun Wang; James D Berry; Jordan R Green
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-03-29       Impact factor: 4.092

7.  Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial.

Authors:  Richard Smith; Erik Pioro; Kathleen Myers; Michael Sirdofsky; Kimberly Goslin; Gregg Meekins; Hong Yu; James Wymer; Merit Cudkowicz; Eric A Macklin; David Schoenfeld; Gary Pattee
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

8.  Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis.

Authors:  Jordan R Green; Kristen M Allison; Claire Cordella; Brian D Richburg; Gary L Pattee; James D Berry; Eric A Macklin; Erik P Pioro; Richard A Smith
Journal:  Br J Clin Pharmacol       Date:  2018-10-01       Impact factor: 4.335

Review 9.  Clinical Measures of Bulbar Dysfunction in ALS.

Authors:  Yana Yunusova; Emily K Plowman; Jordan R Green; Carolina Barnett; Peter Bede
Journal:  Front Neurol       Date:  2019-02-19       Impact factor: 4.003

10.  Frontal Anatomical Correlates of Cognitive and Speech Motor Deficits in Amyotrophic Lateral Sclerosis.

Authors:  Yana Yunusova; Jamal Ansari; Joel Ramirez; Sanjana Shellikeri; Greg J Stanisz; Sandra E Black; Susan M Gillingham; Alex Kiss; Donald T Stuss; Lorne Zinman
Journal:  Behav Neurol       Date:  2019-03-13       Impact factor: 3.342

View more
  6 in total

1.  Validating Automatic Diadochokinesis Analysis Methods Across Dysarthria Severity and Syllable Task in Amyotrophic Lateral Sclerosis.

Authors:  Chelsea Tanchip; Diego L Guarin; Scotia McKinlay; Carolina Barnett; Sanjay Kalra; Angela Genge; Lawrence Korngut; Jordan R Green; James Berry; Lorne Zinman; Azadeh Yadollahi; Agessandro Abrahao; Yana Yunusova
Journal:  J Speech Lang Hear Res       Date:  2022-02-16       Impact factor: 2.674

2.  "You Say Severe, I Say Mild": Toward an Empirical Classification of Dysarthria Severity.

Authors:  Kaila L Stipancic; Kira M Palmer; Hannah P Rowe; Yana Yunusova; James D Berry; Jordan R Green
Journal:  J Speech Lang Hear Res       Date:  2021-11-11       Impact factor: 2.674

3.  Validation of Articulatory Rate and Imprecision Judgments in Speech of Individuals With Amyotrophic Lateral Sclerosis.

Authors:  Ashley A Waito; Farah Wehbe; Reeman Marzouqah; Carolina Barnett; Sanjana Shellikeri; Cindy Cui; Agessandro Abrahao; Lorne Zinman; Jordan R Green; Yana Yunusova
Journal:  Am J Speech Lang Pathol       Date:  2020-12-08       Impact factor: 2.408

4.  Protocol for psychometric evaluation of the Amyotrophic Lateral Sclerosis - Bulbar Dysfunction Index (ALS-BDI): a prospective longitudinal study.

Authors:  Yana Yunusova; Ashley Waito; Carolina Barnett; Anna Huynh; Rosemary Martino; Agessandro Abrahao; Gary L Pattee; James D Berry; Lorne Zinman; Jordan R Green
Journal:  BMJ Open       Date:  2022-03-08       Impact factor: 2.692

5.  Rate of speech decline in individuals with amyotrophic lateral sclerosis.

Authors:  Marziye Eshghi; Yana Yunusova; Kathryn P Connaghan; Bridget J Perry; Marc F Maffei; James D Berry; Lorne Zinman; Sanjay Kalra; Lawrence Korngut; Angela Genge; Annie Dionne; Jordan R Green
Journal:  Sci Rep       Date:  2022-09-20       Impact factor: 4.996

6.  Two Distinct Clinical Phenotypes of Bulbar Motor Impairment in Amyotrophic Lateral Sclerosis.

Authors:  Kaila L Stipancic; Yana Yunusova; Thomas F Campbell; Jun Wang; James D Berry; Jordan R Green
Journal:  Front Neurol       Date:  2021-06-16       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.